Inovalon Holdings Inc  

(Public, NASDAQ:INOV)   Watch this stock  
Find more results for INOV
11.25
-0.05 (-0.44%)
Jan 20 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 11.20 - 11.45
52 week 8.60 - 20.05
Open 11.35
Vol / Avg. 250,647.00/1.83M
Mkt cap 1.65B
P/E 40.49
Div/yield     -
EPS 0.28
Shares 63.06M
Beta     -
Inst. own 63%
Feb 23, 2017
Q4 2016 Inovalon Holdings Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Dec 13, 2016
Inovalon Holdings Inc annual Investor Day
Dec 12, 2016
Inovalon Holdings Inc Guidance Call - Webcast
Nov 2, 2016
Q3 2016 Inovalon Holdings Inc Earnings Call - Webcast
Nov 2, 2016
Q3 2016 Inovalon Holdings Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin 7.43% 15.11%
Operating margin 8.60% 26.63%
EBITD margin - 31.81%
Return on average assets 2.83% 9.08%
Return on average equity 4.16% 18.06%
Employees 2,019 -
CDP Score - -

Address

4321 Collington Rd
BOWIE, MD 20716-2259
United States - Map
+1-301-8094000 (Phone)
+1-301-8098060 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Inovalon Holdings, Inc. is a technology company. The Company combines advanced cloud-based data analytics and data-driven intervention platforms to provide services for health plans, hospitals, physicians, patients, pharmaceutical companies and researchers. The Company operates through developing cloud-based data analytics and data-driven intervention platforms segment and provides related services to its clients. The Company's datasets, integration technologies, predictive analytics and subject matter expertise allows the Company to provide platforms. Its analytics platforms identify gaps in care, quality, data integrity and financial performance in its clients' datasets. The Company's data analytics and intervention platforms consist of four primary components: data integration, advanced analytics, intervention platforms and business processing. The Company integrates data into its systems through its Extract, Transform, Load (ETL) tools and processes.

Officers and directors

Keith R. Dunleavy M.D. Chairman of the Board, Chief Executive Officer
Age: 46
Bio & Compensation  - Reuters
Robert A. Wychulis President
Age: 61
Bio & Compensation  - Reuters
Christopher E. Greiner Chief Financial Officer, Chief Operating Officer, Treasurer
Age: 41
Bio & Compensation  - Reuters
Daniel N. Mendelson President of Avalere Health
Age: 51
Bio & Compensation  - Reuters
Joseph R. Rostock Chief Technology Officer
Age: 53
Bio & Compensation  - Reuters
Jason Z. Rosenberg Chief Strategic Development Officer
Age: 44
Bio & Compensation  - Reuters
Shauna L. Vernal Chief Legal Officer, Corporate Secretary
Age: 46
Bio & Compensation  - Reuters
William D. Green Director
Age: 63
Bio & Compensation  - Reuters
Denise Koen Fletcher Independent Director
Age: 67
Bio & Compensation  - Reuters
Andre S. Hoffmann Independent Director
Age: 57
Bio & Compensation  - Reuters